Free Trial

Baudax Bio (BXRX) Short Interest Ratio & Short Volume

Notice: This company has been marked as potentially delisted and may not be actively trading.

Baudax Bio Short Interest Data

Current Short Interest
473,100 shares
Previous Short Interest
474,300 shares
Change Vs. Previous Month
-0.25%
Dollar Volume Sold Short
$88,043.91
Short Interest Ratio
0.1 Days to Cover
Last Record Date
November 15, 2023
Outstanding Shares
52,460,000 shares
Float Size
42,620,000 shares
Short Percent of Float
1.11%
Today's Trading Volume
310,800 shares
Average Trading Volume
281,029 shares
Today's Volume Vs. Average
111%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Baudax Bio ?

Sign up to receive the latest short interest report for Baudax Bio and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BXRX Short Interest Over Time

BXRX Days to Cover Over Time

BXRX Percentage of Float Shorted Over Time

Baudax Bio Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/2023473,100 shares $88,043.91 -0.3%1.1%0.1 $0.19
10/31/2023474,300 shares $86,417.46 -3.9%5.3%0.1 $0.18
10/15/2023493,600 shares $129,816.80 +1,282.6%5.5%0.1 $0.26
9/30/202335,700 shares $13,212.57 +174.6%0.4%0 $0.37
9/15/202313,000 shares $4,680.00 -68.5%0.1%0 $0.36
8/31/202341,200 shares $17,757.20 -71.1%0.5%0 $0.43
8/15/2023142,700 shares $82,066.77 -27.8%1.7%0.1 $0.58
7/31/2023197,700 shares $136,413.00 -50.1%2.8%0.1 $0.69
7/15/2023396,100 shares $320,801.39 +690.6%6.7%0.1 $0.81
6/30/202350,100 shares $58,617.00 +347.3%0.8%0 $1.17
6/15/202311,200 shares $6,272.00 -81.3%0.4%0 $0.56
5/31/202359,800 shares $31,389.02 -32.1%2.3%0 $0.52
5/15/202388,000 shares $55,528.00 -90.0%3.4%0.1 $0.63
4/30/2023876,300 shares $672,998.40 +576.2%34.0%0.8 $0.77
4/15/2023129,600 shares $217,728.00 -36.7%5.0%0.1 $1.68
3/31/2023204,800 shares $348,160.00 +369.7%7.9%0.2 $1.70
3/15/202343,600 shares $57,988.00 +12.7%1.7%0 $1.33
2/28/202338,700 shares $85,140.00 -19.0%1.5%0 $2.20
2/15/202347,800 shares $147,224.00 -47.7%8.6%0 $3.08
1/31/202391,300 shares $269,335.00 +56.9%18.6%0 $2.95
1/15/202358,200 shares $197,880.00 -7.0%11.8%0 $3.40
12/30/202262,600 shares $199,068.00 -28.9%12.7%0.1 $3.18
12/15/202288,100 shares $226,417.00 +149.6%N/A0.1 $2.57
11/30/202235,300 shares $5,136.15 -93.8%N/A0.5 $0.15
11/15/2022571,700 shares $94,216.16 +31.2%2.9%0.3 $0.16
10/31/2022435,900 shares $89,054.37 +20.4%2.3%0.2 $0.20
10/15/2022362,100 shares $78,177.39 +6.6%1.9%0.2 $0.22
9/30/2022339,600 shares $83,507.64 +8.3%4.3%0.2 $0.25
9/15/2022313,500 shares $103,204.20 -87.8%3.9%0.2 $0.33
8/31/20222,560,000 shares $834,560.00 +1,008.2%32.9%2 $0.33
8/15/2022231,000 shares $173,250.00 +126.9%3.8%1.5 $0.75
7/31/2022101,800 shares $71,534.86 -11.1%1.7%0.6 $0.70
7/15/2022114,500 shares $87,317.70 -3.6%1.9%0.7 $0.76
6/30/2022118,800 shares $100,386.00 -73.6%2.0%0.7 $0.85
6/15/2022449,500 shares $341,620.00 +46.9%7.4%2.1 $0.76
5/31/2022305,900 shares $232,484.00 +116.3%4.8%1 $0.76
5/15/2022141,400 shares $156,954.00 -24.8%2.2%0.3 $1.11
4/30/2022188,100 shares $287,793.00 -19.4%3.0%0.4 $1.53
4/15/2022233,500 shares $427,305.00 -17.7%3.7%0.5 $1.83
3/31/2022283,700 shares $502,149.00 +57.7%4.5%0.6 $1.77
[Urgent!] Generational Wealth Gameplan (Ad)

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide
3/15/2022179,900 shares $291,438.00 -22.8%2.9%0.4 $1.62
2/28/2022233,000 shares $440,370.00 +67.5%5.0%0.6 $1.89
2/15/2022139,100 shares $24,968.45 -97.4%N/A0.6 $0.18
1/31/20225,370,000 shares $1.00 million +383.8%6.5%1.3 $0.19
1/15/20221,110,000 shares $223,998.00 -40.3%1.3%0.3 $0.20
12/31/20211,860,000 shares $407,712.00 -13.5%2.3%0.8 $0.22
12/15/20212,150,000 shares $661,555.00 -11.9%2.6%1.9 $0.31
11/30/20212,440,000 shares $918,904.00 +2.1%3.0%2.2 $0.38
11/15/20212,390,000 shares $1.19 million -18.7%2.9%1.3 $0.50
10/29/20212,940,000 shares $1.53 million +16.7%3.6%0.9 $0.52
10/15/20212,520,000 shares $1.40 million +2.0%3.1%0.8 $0.56
9/30/20212,470,000 shares $1.39 million -13.3%3.0%0.8 $0.56
9/15/20212,850,000 shares $1.75 million -28.8%3.5%0.9 $0.62
8/31/20214,000,000 shares $2.52 million +145.4%4.9%1.2 $0.63
8/13/20211,630,000 shares $859,988.00 +5.8%2.0%0.7 $0.53
7/30/20211,540,000 shares $939,708.00 -15.9%1.9%1 $0.61
7/15/20211,830,000 shares $1.14 million +173.5%2.2%1 $0.62
6/30/2021669,000 shares $508,908.30 +2.2%0.8%0.4 $0.76
6/15/2021654,500 shares $519,149.40 -84.7%0.8%0.4 $0.79
5/28/20214,290,000 shares $3.87 million -9.9%N/A2.2 $0.90
5/14/20214,760,000 shares $3.64 million +2.2%6.9%2.2 $0.77
4/30/20214,660,000 shares $5.36 million +6.9%6.7%1.2 $1.15
4/15/20214,360,000 shares $4.93 million +12.7%6.3%1 $1.13
3/31/20213,870,000 shares $4.95 million +55.4%5.6%0.7 $1.28
3/15/20212,490,000 shares $3.49 million -29.9%3.6%0.4 $1.40
2/26/20213,550,000 shares $4.97 million +5.0%5.1%0.6 $1.40
2/12/20213,380,000 shares $6.29 million +11.6%4.9%0.6 $1.86
1/29/20213,030,000 shares $4.12 million -27.2%6.4%0.6 $1.36
1/15/20214,160,000 shares $5.53 million +199.3%11.1%1.1 $1.33
12/31/20201,390,000 shares $1.40 million +0.7%4.9%0.5 $1.01
12/15/20201,380,000 shares $1.50 million -13.2%4.9%0.7 $1.09
11/30/20201,590,000 shares $1.83 million +141.2%5.5%1.1 $1.15
11/15/2020659,100 shares $725,010.00 +95.4%2.6%0.7 $1.10
10/30/2020337,300 shares $381,149.00 -78.8%1.9%0.4 $1.13
10/15/20201,590,000 shares $4.29 million -6.5%8.8%2.5 $2.70
9/30/20201,700,000 shares $4.71 million -11.5%9.4%4 $2.77
9/15/20201,920,000 shares $6.57 million +39.1%10.7%3.5 $3.42
8/31/20201,380,000 shares $3.86 million -16.9%7.7%2.2 $2.80
8/14/20201,660,000 shares $4.37 million -19.4%9.2%2.7 $2.63
7/31/20202,060,000 shares $7.25 million -7.6%11.4%2.6 $3.52
7/15/20202,230,000 shares $7.85 million -13.9%12.9%2.5 $3.52
6/30/20202,590,000 shares $11.29 million +3.2%15.0%2.8 $4.36
6/15/20202,510,000 shares $9.91 million +6.4%14.5%2.5 $3.95
5/29/20202,360,000 shares $10.36 million +19.2%13.7%2.5 $4.39
5/15/20201,980,000 shares $8.59 million +4.2%11.5%2.2 $4.34
4/30/20201,900,000 shares $5.85 million +214.6%10.9%2.2 $3.08
4/15/2020604,000 shares $1.42 million -52.4%3.5%0.9 $2.35
3/31/20201,270,000 shares $3.67 million -31.9%7.5%2 $2.89
3/13/20201,864,200 shares $4.49 million -7.3%21.1%4.9 $2.41
2/28/20202,010,000 shares $8.78 million +107.2%22.7%5.1 $4.37
[Urgent!] Generational Wealth Gameplan (Ad)

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide
2/14/2020969,900 shares $5.40 million +15.6%11.0%2.6 $5.57
1/31/2020839,100 shares $6.09 million +14.9%9.6%4.7 $7.26
1/15/2020730,400 shares $5.97 million +14.8%8.3%3.9 $8.17
12/31/2019636,500 shares $5.29 million No Change7.3%3.7 $8.31

BXRX Short Interest - Frequently Asked Questions

What is Baudax Bio's current short interest?

Short interest is the volume of Baudax Bio shares that have been sold short but have not yet been closed out or covered. As of November 15th, investors have sold 473,100 shares of BXRX short. 1.11% of Baudax Bio's shares are currently sold short. Learn More on Baudax Bio's current short interest.

What is a good short interest percentage for Baudax Bio?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.11% of Baudax Bio's floating shares are currently sold short.

Is Baudax Bio's short interest increasing or decreasing?

Baudax Bio saw a drop in short interest in November. As of November 15th, there was short interest totaling 473,100 shares, a drop of 0.3% from the previous total of 474,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Baudax Bio's float size?

Baudax Bio currently has issued a total of 52,460,000 shares. Some of Baudax Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Baudax Bio currently has a public float of 42,620,000 shares.

How does Baudax Bio's short interest compare to its competitors?

1.11% of Baudax Bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Baudax Bio: Bio-Path Holdings, Inc. (1.54%), Allarity Therapeutics, Inc. (2.96%), Virpax Pharmaceuticals, Inc. (5.07%), NeuBase Therapeutics, Inc. (0.51%), SciSparc Ltd. (2.36%), Panbela Therapeutics, Inc. (2.36%), Sunshine Biopharma, Inc. (0.97%), Dermata Therapeutics, Inc. (1.46%), PainReform Ltd. (1.55%), GRI Bio, Inc. (0.65%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Baudax Bio stock?

Short selling BXRX is an investing strategy that aims to generate trading profit from Baudax Bio as its price is falling. BXRX shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Baudax Bio?

A short squeeze for Baudax Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BXRX, which in turn drives the price of the stock up even further.

How often is Baudax Bio's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BXRX, twice per month. The most recent reporting period available is November, 15 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:BXRX) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners